WASHINGTON, Jan. 27, 2011 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that GAAP net earnings for the quarter ended December 31, 2010 were $473.9 million, or $0.69 per diluted share, a 72.5% increase over GAAP diluted net earnings per share of $0.40 for the fourth quarter 2009. On a non-GAAP basis, which reflects the adjustments identified in the attached reconciliation schedule, 2010 fourth quarter adjusted net earnings were $455.4 million, or $0.67 per diluted share, a 19.5% increase over 2009 fourth quarter adjusted diluted net earnings per share of $0.56. Sales for the 2010 fourth quarter were $3.6 billion, 15% higher than the $3.1 billion reported for the 2009 fourth quarter. Core revenues increased 13% in the quarter compared to the fourth quarter of 2009.

GAAP net earnings for the full year 2010 were $1.8 billion, or $2.64 per diluted share, compared with GAAP net earnings of $1.2 billion, or $1.73 per diluted share for the full year 2009. Revenues for the full year 2010 were $13.2 billion compared to $11.2 billion for the full year 2009, an increase of 18%. Core revenues increased 11.5% for the full year 2010 compared to the full year 2009.

H. Lawrence Culp, Jr., President and Chief Executive Officer, stated, "2010 was an outstanding year for Danaher. We continued to evolve the portfolio toward higher growth, higher technology, more global businesses serving markets where our brands are clear leaders. The investments we have made in innovation and emerging markets are driving growth and share gains. We generated $1.87 billion of free cash flow in 2010 and continue to seek to deploy our cash back into the business through acquisitions. We believe we are well positioned heading into 2011."

Danaher will discuss its results during its investor conference call today starting at 8:00 a.m. EST. The call and an accompanying slide presentation will be webcast on the "Investors" section of Danaher's website at www.danaher.com. A replay of the webcast can be accessed on the "Investors" section of Danaher's website (under the subheading "Investor Events") shortly after the conclusion of the presentation, and the webcast will remain available until the next quarterly earnings call. The conference call can be accessed by dialing 888-857-6931 within the U.S. or 719-457-1529 outside the U.S. a few minutes before the 8:00 a.m. EST start and telling the operator that you are dialing in for Danaher's earnings conference call (access code 4535370). A replay of the conference call will be available shortly after the conclusion of the call and through Tuesday, February 1, 2011. You can access the replay by dialing 888-203-1112 within the U.S. or 719-457-0820 outside the U.S. with the access code 4535370.

In addition, presentation materials relating to Danaher's results have been posted to the "Investors" section of Danaher's website under the subheading "Earnings."

Danaher is a diversified technology leader that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. Our portfolio of premier brands is among the most highly recognized in each of the markets we serve. Driven by a foundation provided by the Danaher Business System, our 48,000 associates serve customers in more than 125 countries and generated $13.2 billion of revenue in 2010. For more information please visit our website: www.danaher.com.

In addition to the financial measures prepared in accordance with generally accepted accounting principles (GAAP), this earnings announcement also contains non-GAAP financial measures. The reasons why we believe these measures provide useful information to investors, a reconciliation of these measures to the most directly comparable GAAP measures and other information relating to these measures are included in the supplemental reconciliation schedule attached.

Statements in this release that are not strictly historical, including the statements regarding the growth and technology profile of the Company's business portfolio, the impact of the Company's investments in innovation and emerging markets, the Company's positioning and expectations for 2011 and any other statements regarding events or developments that we believe or anticipate will or may occur in the future, may be "forward-looking" statements within the meaning of the federal securities laws. There are a number of important factors that could cause actual events to differ materially from those suggested or indicated by such forward-looking statements and you should not place undue reliance on any such forward-looking statements. These factors include, among other things, uncertainty in the economy and financial markets, the impact of our restructuring activities on our ability to grow, contractions or growth rates and cyclicality of markets we serve, competition, our ability to develop and successfully market new products and technologies and expand into new markets, our ability to successfully identify, consummate and integrate appropriate acquisitions, contingent liabilities relating to acquisitions, risks relating to potential impairment of goodwill and other long-lived assets, currency exchange rates, our compliance with applicable laws and regulations and changes in applicable laws and regulations, tax audits and changes in our tax rate and income tax liabilities, litigation and other contingent liabilities including intellectual property and environmental matters, risks relating to product defects and recalls, the impact of our debt obligations on our operations, pension plan costs, commodity costs and surcharges, our ability to adjust purchases and manufacturing capacity to reflect market conditions, legislative health care reform and other changes in health care industry, labor matters, our relationships with and the performance of our channel partners, risks relating to man-made and natural disasters, our ability to achieve projected cost reductions and growth, and international economic, political, legal and business factors. Additional information regarding the factors that may cause actual results to differ materially from these forward-looking statements is available in our SEC filings, including our 2009 Annual Report on Form 10-K and our Quarterly Report on Form 10-Q for the third quarter of 2010. These forward-looking statements speak only as of the date of this release and the Company does not assume any obligation to update or revise any forward-looking statement, whether as a result of new information, future events and developments or otherwise.

               DANAHER CORPORATION AND SUBSIDIARIES
                CONSOLIDATED STATEMENTS OF EARNINGS
                            (unaudited)

    ($ in thousands, except per share amounts)

                         Three Months Ended                 Year Ended
                        12/31/10      12/31/09       12/31/10     12/31/09
                        --------      --------       --------     --------

    Sales             $3,609,268    $3,132,892    $13,202,602  $11,184,938
    Cost of
     sales             1,768,797     1,694,507      6,575,812    5,904,718
                       ---------     ---------      ---------    ---------
    Gross
     profit            1,840,471     1,438,385      6,626,790    5,280,220

     Operating
     costs
     and
     other:
      Selling,
       general
       and
       administrative
       expenses        1,004,173       890,455  3,673,703    3,190,211
      Research
       and
       development
       expenses          222,008       154,216        809,481      632,651
      Earnings
       from
       unconsolidated
       joint
       venture           (12,218)           --    (22,768)          --
      Other
       income                 --            --             --      (85,118)
                             ---           ---            ---      -------

     Operating
     profit              626,508       393,714      2,166,374    1,542,476

    Non-
     operating
     income
     (expense):
       Gain on
        contribution
        of
        businesses
        to
        joint
        venture               --            --    291,037           --
       Interest
        expense          (28,647)      (35,428)      (120,775)    (122,656)
       Interest
        income             1,700         1,649          6,069        5,034
                           -----         -----          -----        -----

    Earnings
     before
     income
     taxes               599,561       359,935      2,342,705    1,424,854

    Income
     taxes              (125,705)      (93,000)      (549,705)    (273,150)
                        --------       -------       --------     --------

    Net
     earnings           $473,856      $266,935     $1,793,000   $1,151,704
                        ========      ========     ==========   ==========

    Net
     earnings
     per
     share:
        Basic              $0.72         $0.41          $2.74        $1.80
                           -----         -----          -----        -----
        Diluted            $0.69         $0.40          $2.64        $1.73
                           =====         =====          =====

    Average
     common
     stock
     and
     common
     equivalent
     shares
     outstanding:
        Basic            656,733       645,432        653,194      641,530
        Diluted          687,207       677,360        683,275      671,484

      This information is presented for reference only.  Final audited
        financial statements will include footnotes, which should be
    referenced when available, to more fully understand the contents of
                              this information.

                       DANAHER CORPORATION AND SUBSIDIARIES
                           CONSOLIDATED BALANCE SHEETS
                                   (unaudited)

    As of December 31 ($ and shares in thousands)

    ASSETS                                                2010        2009
                                                          ----        ----

    Current Assets:
        Cash and equivalents                        $1,632,980  $1,721,920
        Trade accounts receivable, less allowance
         for doubtful accounts of $136,648 and
         $133,103, respectively                      2,218,975   1,916,831
        Inventories                                  1,225,151     993,016
        Prepaid expenses and other current assets      652,407     588,861
                                                       -------     -------
           Total current assets                      5,729,513   5,220,628

    Property, plant and equipment, net               1,192,303   1,143,331
    Investment in joint venture                        511,283          --
    Other assets                                       701,127     758,035
    Goodwill                                        10,758,402   9,817,923
    Other intangible assets, net                     3,324,502   2,655,503
                                                     ---------   ---------

         Total assets                              $22,217,130 $19,595,420
                                                   =========== ===========

    LIABILITIES AND STOCKHOLDERS' EQUITY

    Current Liabilities:
        Notes payable and current portion of long-
         term debt                                     $40,761     $44,186
        Trade accounts payable                       1,215,818   1,051,487
        Accrued expenses and other liabilities       2,048,175   1,665,287
                                                     ---------   ---------
           Total current liabilities                 3,304,754   2,760,960

    Other long-term liabilities                      2,355,703   2,315,261
    Long-term debt                                   2,783,907   2,889,023
    Stockholders' equity:
        Common stock -$0.01 par value, 1 billion
         shares authorized; 729,516 and 717,844
         issued; 656,360 and 645,470 outstanding,
         respectively                                    7,295       3,589
        Additional paid-in capital                   2,412,401   2,074,501
        Retained earnings                           10,945,928   9,205,142
        Accumulated other comprehensive income
         (loss)                                        345,386     346,944
                                                       -------     -------
           Total Danaher stockholders' equity       13,711,010  11,630,176
        Non-controlling interest                        61,756          --
                                                        ------
           Total stockholders' equity               13,772,766  11,630,176
                                                    ----------  ----------

     Total liabilities and stockholders' equity    $22,217,130 $19,595,420
                                                   =========== ===========

         This information is presented for reference only.  Final audited
           financial statements will include footnotes, which should be
       referenced when available, to more fully understand the contents of
                                this information.

                   DANAHER CORPORATION AND SUBSIDIARIES
                  CONSOLIDATED STATEMENTS OF CASH FLOWS
                               (unaudited)

    Year Ended December 31 ($ in thousands)

                                                           2010         2009
                                                           ----         ----
    Cash flows from operating
     activities:
       Net earnings                                  $1,793,000   $1,151,704
       Non-cash items:
          Depreciation                                  197,998      184,524
          Amortization                                  199,084      157,063
          Stock compensation expense                     88,122       87,350
          Earnings from unconsolidated joint
           venture                                      (22,768)          --
          Pre-tax gain on contribution of
           businesses to joint venture                 (291,037)          --
          Consideration received in shares                   --      (84,749)
       Change in deferred income taxes                   43,353     (154,098)
       Change in trade accounts
        receivable, net                                (262,123)     106,132
       Change in inventories                           (166,454)     211,595
       Change in accounts payable                       224,711      (89,853)
       Change in prepaid expenses and
        other assets                                     70,715      142,396
       Change in accrued expenses and
        other liabilities                               209,750       88,770
                                                        -------       ------
               Net cash flows from operating
                activities                            2,084,351    1,800,834
                                                      ---------    ---------

    Cash flows from investing
     activities:
       Payments for additions to property,
        plant and equipment                            (217,328)    (188,547)
       Proceeds from disposals of
        property, plant and equipment                     1,559        6,090
       Proceeds from contribution of
        businesses to joint venture                      56,542           --
       Cash paid for acquisitions                    (2,129,652)    (703,511)
       Cash paid for other investments                       --      (66,768)
       Proceeds from divestitures                            --        9,795
               Net cash used in investing
                activities                           (2,288,879)    (942,941)
                                                     ----------     --------

    Cash flows from financing
     activities:
       Proceeds from issuance of common
        stock                                           178,406      174,233
       Payment of dividends                             (52,214)     (41,717)
       Purchase of treasury stock                            --           --
       Net (repayments) proceeds of
        borrowings (maturities of 90 days
        or less)                                             --     (445,711)
       Proceeds of borrowings (maturities
        longer than 90 days)                                 --      744,615
       Repayments of borrowings
        (maturities longer than 90 days)                 (9,388)     (24,188)
                                                         ------      -------
               Net cash provided by (used in)
                financing activities                    116,804      407,232
                                                        -------      -------

    Effect of exchange rate changes on
     cash and equivalents                                (1,216)      63,941
                                                         ------       ------
               Net change in cash and equivalents       (88,940)   1,329,066

    Beginning balance of cash and
     equivalents                                      1,721,920      392,854
    Ending balance of cash and
     equivalents                                     $1,632,980   $1,721,920
                                                     ==========   ==========

     This information is presented for reference only.  Final audited
        financial statements will include footnotes, which should be
    referenced when available, to more fully understand the contents of
                             this information.

                       DANAHER CORPORATION AND SUBSIDIARIES
                                SEGMENT INFORMATION

    ($ in millions, unaudited)

    Sales                  Three Months Ended               Year Ended
    -----                  ------------------               ----------
                          12/31/10       12/31/09   12/31/10        12/31/09
                          --------       --------   --------        --------
    Test & Measurement      $801.4         $597.9   $2,832.9        $2,221.3
    Environmental            751.7          699.6    2,738.0         2,418.7
    Life Sciences &
     Diagnostics             681.9          432.1    2,298.3         1,484.9
    Dental                   521.5          489.0    1,824.6         1,657.0
    Industrial
     Technologies            852.8          747.8    3,193.2         2,795.1
    Businesses
     contributed to
     Apex JV
     attributable to
     periods prior to
     contribution               --          166.5   315.6           607.9
                               ---          -----      -----           -----

                          $3,609.3       $3,132.9  $13,202.6       $11,184.9
                          ========       ========  =========       =========

    Operating Profit
    ----------------

    Test & Measurement      $158.8         $111.1     $572.9          $301.4
    Environmental            166.3          127.1      564.3           471.0
    Life Sciences &
     Diagnostics              89.6           54.3      227.9           179.6
    Dental                    63.2           23.7      203.3           215.9
    Industrial
     Technologies            161.3           89.2      630.1           400.2
    Businesses
     contributed to
     Apex joint
     venture:
        Attributable to
         periods prior to
         contribution           --           11.3       41.5            63.9
        Equity method
         earnings
         subsequent to JV
         formation            12.2             --       22.8              --
    Other                    (24.9)         (23.0)     (96.4)          (89.6)
                             -----          -----      -----           -----

                            $626.5         $393.7   $2,166.4        $1,542.4
                            ======         ======   ========        ========

    Operating Margins
    -----------------

    Test & Measurement        19.8%          18.6%      20.2%           13.6%
    Environmental             22.1%          18.2%      20.6%           19.5%
    Life Sciences &
     Diagnostics              13.1%          12.6%       9.9%           12.1%
    Dental                    12.1%           4.8%      11.1%           13.0%
    Industrial
     Technologies             18.9%          11.9%      19.7%           14.3%

    Total                     17.4%          12.6%      16.4%           13.8%

         This information is presented for reference only.  Final audited
           financial statements will include footnotes, which should be
        referenced when available, to more fully understand the contents of
                                 this information

    DANAHER CORPORATION
    RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES
    ($ in 000's except per share data)

                                           Three Months Ended
                                           ------------------
                                      December 31,   December 31,
    Adjusted Net Earnings                 2010           2009      % Change
    ---------------------            -------------  -------------  --------

    Net Earnings (GAAP)                   $473,856       $266,935      77.5%
                                                                       ====

      Acquisition-related
       transaction costs deemed
       significant                           5,774         14,250
       ($0 and $8 million pre-tax
        for the three months and
        year
      ended December 31, 2010,
       respectively, and $12
       million
      and $24 million pre-tax for
       the three months and year
      ended December 31, 2009,
       respectively), and fair
       value
       adjustments to acquisition
        related inventory and
        deferred
       revenue balances ($8 million
        and $54 million pre-tax
        for the
       three months and year ended
        December 31, 2010,
        respectively,
      and $3 million and $13
       million pre-tax for the
       three months
      and year ended December 31,
       2009, respectively)
       ("Acquisition Related
        Costs")

      Gain on contribution of
       assets to Apex joint
       venture                                   -              -
      ($291 million pre-tax for
       year ended December 31,
       2010) ("Joint Venture Gain")

      Gains from net reduction in
       income tax                          (24,185)             -
      reserves, other discrete tax
       items and
      reduction of effective tax
       rate ("Income Tax Items")

      Gain on intellectual
       property litigation
       settlement                                -              -
      with Align Technology, Inc
       ($85 million pre-tax
      for the year ended December
       31, 2009) ("Align
      Settlement Gain)

      Restructuring charges in
       excess of amounts                         -         93,750
      originally budgeted for the
       applicable period
      ($125 million and $190
       million pre-tax for the
      three months and year ended
       December 31,
        2009, respectively)
         ("Additional
         Restructurings")


    Adjusted Net Earnings (Non-
     GAAP)                                $455,445       $374,935      21.5%
                                          ========       ========      ====

    Adjusted Diluted Net
     Earnings Per Share
    --------------------

    Net Earnings Per Diluted
     Share (GAAP)                            $0.69          $0.40      72.5%
                                                                       ====

      Acquisition Related Costs               0.01           0.02

      Joint Venture Gain                         -              -

      Income Tax Items                       (0.03)             -

      Align Settlement Gain                      -              -

      Additional Restructurings                  -           0.14


    Adjusted Diluted Net
     Earnings Per Share (Non-
     GAAP)                                   $0.67          $0.56      19.6%
                                             =====          =====      ====

                                            Year Ended
                                            ----------
                                    December 31,    December 31,
    Adjusted Net Earnings                2010            2009      % Change
    ---------------------           -------------   -------------  --------

    Net Earnings (GAAP)                $1,793,000      $1,151,704       55.7%
                                                                        ====

      Acquisition-related
       transaction costs deemed
       significant                         46,445          31,767
       ($0 and $8 million pre-tax
        for the three months and
        year
      ended December 31, 2010,
       respectively, and $12
       million
      and $24 million pre-tax for
       the three months and year
      ended December 31, 2009,
       respectively), and fair
       value
       adjustments to acquisition
        related inventory and
        deferred
       revenue balances ($8 million
        and $54 million pre-tax
        for the
       three months and year ended
        December 31, 2010,
        respectively,
      and $3 million and $13
       million pre-tax for the
       three months
      and year ended December 31,
       2009, respectively)
       ("Acquisition Related
        Costs")

      Gain on contribution of
       assets to Apex joint
       venture                           (232,200)              -
      ($291 million pre-tax for
       year ended December 31,
       2010) ("Joint Venture Gain")

      Gains from net reduction in
       income tax                         (42,798)        (97,229)
      reserves, other discrete tax
       items and
      reduction of effective tax
       rate ("Income Tax Items")

      Gain on intellectual
       property litigation
       settlement                               -         (53,412)
      with Align Technology, Inc
       ($85 million pre-tax
      for the year ended December
       31, 2009) ("Align
      Settlement Gain)

      Restructuring charges in
       excess of amounts                        -         144,365
      originally budgeted for the
       applicable period
      ($125 million and $190
       million pre-tax for the
      three months and year ended
       December 31,
        2009, respectively)
         ("Additional
         Restructurings")


    Adjusted Net Earnings (Non-
     GAAP)                             $1,564,447      $1,177,195       32.9%
                                       ==========      ==========       ====

    Adjusted Diluted Net
     Earnings Per Share
    --------------------

    Net Earnings Per Diluted
     Share (GAAP)                           $2.64           $1.73       52.6%
                                                                        ====

      Acquisition Related Costs              0.07            0.05

      Joint Venture Gain                    (0.34)              -

      Income Tax Items                      (0.06)          (0.15)

      Align Settlement Gain                     -           (0.08)

      Additional Restructurings                 -            0.22


    Adjusted Diluted Net
     Earnings Per Share (Non-
     GAAP)                                  $2.31           $1.77       30.5%
                                            =====           =====       ====

    Core Revenue Growth
    -------------------

                                                 Three Months
                                                     Ended       Year Ended
                                                 December 31,   December 31,
                                                   2010 vs.       2010 vs.
                                                  Comparable     Comparable
      Components of Sales Growth                 2009 Period    2009 Period
      --------------------------                -------------  -------------

      Core (non-GAAP)                                    13.0%          11.5%
      Acquisitions (non-GAAP)                             3.5%           7.0%
      Impact of currency translation (non-GAAP)          -1.5%          -0.5%
                                                         ----           ----
      Total Sales Growth (GAAP)                          15.0%          18.0%
                                                         ====           ====


    Free Cash Flow
    --------------
                                                  Year Ended
                                                 December 31,
                                                     2010
                                                -------------

      Operating Cash Flow (GAAP)                   $2,084,351
      Less: Purchases of Property, Plant &
       Equipment                                     (217,328)
                                                     --------
      Free Cash Flow (Non-GAAP)                    $1,867,023

Adjusted Net Earnings and Adjusted Diluted Net Earnings Per Share

We disclose the non-GAAP measures of adjusted net earnings and adjusted diluted net earnings per share, which refer to GAAP net earnings and GAAP diluted net earnings per share, respectively, excluding the items identified in the reconciliation schedule above. These non-GAAP measures should be considered in addition to, and not as a replacement for or superior to, the comparable GAAP measures, and may not be comparable to similarly titled measures reported by other companies.

Management believes that these measures provide useful information to investors by reflecting additional ways of viewing aspects of Danaher's operations that, when reconciled to the corresponding GAAP measures, help our investors to better understand the long-term profitability trends of our business, and facilitate easier comparisons of our profitability to prior and future periods and to our peers. The items described above have been excluded from these measures because items of this nature and/or size occur with inconsistent frequency, for reasons that may be unrelated to Danaher's commercial performance during the period and/or we believe are not indicative of Danaher's ongoing operating costs or gains in a given period, which we believe may obscure underlying business trends and make comparisons of long-term performance difficult. At the beginning of 2010, management communicated that it expects to incur approximately $35 million (approximately $0.04 per share) of acquisition-related transaction costs during 2010. Acquisition-related transaction costs incurred during a quarter in excess of $13.5 million (approximately $0.02 per share) are deemed significant.

The Company estimates the tax effect of the items identified in the reconciliation schedule above by applying the Company's overall estimated effective tax rate to the pre-tax amount, unless the nature of the item and/or the tax jurisdiction in which the item has been recorded requires application of a specific tax rate or tax treatment, in which case the tax effect of such item is estimated by applying such specific tax rate or tax treatment.

Core Revenue and Core Revenue Growth

We use the term "core revenue" or "sales from existing businesses" to refer to GAAP revenue excluding (1) sales from acquired businesses recorded prior to the first anniversary of the acquisition ("acquisition sales"), (2) second half 2009 sales attributable to the businesses contributed to the Apex joint venture, and (3) the impact of currency translation. The portion of GAAP revenue attributable to currency translation is calculated as the difference between (a) the period-to-period change in GAAP revenue (excluding acquisition sales and second half 2009 sales attributable to the businesses contributed to the Apex joint venture) and (b) the period-to-period change in revenue (excluding acquisition sales and second half 2009 sales attributable to the businesses contributed to the Apex joint venture) after applying current period foreign exchange rates to the prior year period. We use the term "core revenue growth" to refer to the measure of comparing current period core revenue with the corresponding period of the prior year. These non-GAAP measures should be considered in addition to, and not as a replacement for or superior to, the comparable GAAP measures, and may not be comparable to similarly titled measures reported by other companies.

Management believes that these measures provide useful information to investors by reflecting additional ways of viewing aspects of Danaher's operations that, when reconciled to the corresponding GAAP measures, help our investors to better identify underlying growth trends in our business and facilitate easier comparisons of our revenue performance with prior and future periods and to our peers. We exclude the effect of currency translation from these measures because currency translation is not under management's control, is subject to volatility and can obscure underlying business trends. We exclude the effect of acquisitions because the nature, size and number of acquisitions can vary dramatically from period to period and between us and our peers, which we believe may obscure underlying business trends and make comparisons of long-term performance difficult. We exclude the effect of the second half 2009 sales attributable to the businesses contributed to the Apex joint venture because as a result of application of the equity method of accounting beginning with the formation of the joint venture on July 4, 2010, the Company did not recognize sales from those businesses in the second half of 2010.

Free Cash Flow

We disclose the non-GAAP measure of free cash flow, defined above. This measure should be considered in addition to, and not as a replacement for or superior to, GAAP operating cash flow, and may not be comparable to similarly titled measures reported by other companies.

Management believes that this measure provides useful information to investors by reflecting additional ways of viewing Danaher's operations that, when reconciled to GAAP operating cash flow, help our investors to better understand the strength of Danaher's earnings as well as Danaher's ability to generate cash without external financings, strengthen its balance sheet, invest in the business and grow the business through acquisitions and other strategic opportunities. A limitation of Danaher's free cash flow measure is that it does not take into account the Company's debt service requirements and other non-discretionary expenditures.

SOURCE Danaher Corporation

SOURCE: Danaher Corporation